Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV-associated lymphomas

D J Straus1

  • 1Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Current Opinion in Oncology
|November 5, 1997
PubMed
Summary
This summary is machine-generated.

Intermediate and high-grade non-Hodgkin's lymphomas (NHL) are AIDS-defining illnesses in HIV-infected individuals. Increased survival due to treatment leads to anticipated further increases in NHL incidence and unusual presentations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Final results of phase II trial of doxorubicin HCl liposome injection followed by bexarotene in advanced cutaneous T-cell lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Chemotherapy only for localized Hodgkin lymphoma.

Journal of internal medicine·2011
Same author

Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience.

Annals of oncology : official journal of the European Society for Medical Oncology·2009
Same author

Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2007
Same author

The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: a sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide.

Annals of oncology : official journal of the European Society for Medical Oncology·2004
Same author

Comparison of survival in cerebral palsy between countries.

Developmental medicine and child neurology·2001
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Infectious Diseases
  • Hematology

Background:

  • Intermediate and high-grade non-Hodgkin's lymphomas (NHL) with a B-cell phenotype are AIDS-defining illnesses.
  • The incidence of systemic NHL and primary central nervous system NHL has significantly increased in the HIV-infected population.
  • Antiretroviral treatment and opportunistic infection management contribute to longer survival in immunosuppressed HIV-infected individuals.

Purpose of the Study:

  • This review focuses on the pathologic and clinical features of HIV-associated lymphomas.
  • It also covers treatment approaches and outcomes for these lymphomas.
  • This review complements other articles discussing epidemiology and pathogenesis.

Main Methods:

  • Literature review of HIV-associated lymphomas.

Related Experiment Videos

  • Analysis of pathologic and clinical features.
  • Evaluation of treatment strategies and results.

    • Main Results:

    • HIV-associated NHL, particularly primary CNS NHL, shows increased incidence in HIV-infected individuals.
    • Longer survival in immunosuppressed individuals is expected to further increase NHL frequency.
    • Unusual NHL types and Hodgkin's disease manifestations occur in HIV-infected patients.

    Conclusions:

    • HIV-associated lymphomas present unique challenges in diagnosis and management.
    • Understanding the evolving landscape of HIV-associated NHL is crucial for effective patient care.
    • Further research into pathogenesis and treatment is warranted.